Aug 13, 2020
Global Market and Forecast Model for Hepatitis C Tests Market 2020 with Coverage of 39 Countries
Aug 13, 2020
Global Hepatitis B Tests Industry 2015-2030: COVID-19 Impact, Revenues by Segment, Total Procedures, Units, ASPs, and Market Values by Segment
Aug 13, 2020
MicuRx Announces CARB-X US$7.78 Million Funding for Development of MRX-8
Jun 17, 2020
$200+ Billion Worldwide Infection Prevention & Control Market to 20207 - Impact of COVID-19
Jun 17, 2020
Armata Pharmaceuticals Announces $15 Million Award from the U.S. Department of Defense (DoD) for Development of Bacteriophage Therapy to Treat S. aureus Bacteremia Infections
May 26, 2020
New Publication Reveals Real-World Usage of Vibativ® In Patients With Bacteremia Or Endocarditis
May 21, 2020
First Light Diagnostics Posters and Abstracts Accepted, Part of ECCMID 2020 Abstract Book
May 19, 2020
Increase in Incidence of Nosocomial Infections to Underscore Growth in Hospital Acquired Disease Testing Market from 2019 to 2027: TMR
May 11, 2020
Vibativ® Sustained Potency Confirmed In Two Surveillance Studies
May 06, 2020
Antabio Receives QIDP Designation From the U.S. FDA for the Development of MEM-ANT3310, a Novel Broad-Spectrum Combination Therapy Targeting WHO's Priority Pathogens
May 04, 2020
Aridis Pharmaceuticals Enrolls Its First COVID-19 Patient in Ongoing Phase 3 AR-301 Clinical Trial in Ventilator Associated Pneumonia (VAP)
Apr 30, 2020
Sarsblog.com Presents The Risks of Reopening the World Without Having A Cure For Covid-19
Apr 23, 2020
Hix Group brings the science of screening for epidemics to the U.S. market to help contain the spread of flu-like illnesses, including COVID-19
Apr 14, 2020
Bausch + Lomb Announces Publication Of 10-Year Armor Study Results On Ocular Antibiotic Resistance In JAMA Ophthalmology
Apr 02, 2020
Reducing Risk of Infection: BlueWillow Biologics to Launch NanoBio® Protect OTC Nasal Antiseptic Solution
Mar 24, 2020
Results from First Clinical Study Using Danoprevir to Treat Naive and Experienced COVID-19 Patients
Mar 23, 2020
Cumberland Pharmaceuticals Announces Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
Mar 19, 2020
FDA Approves New Treatment for Pediatric Patients with Any Strain of Hepatitis C
Mar 18, 2020
Magnolia Medical Partners with Hospitals to Mitigate Critical Constraints Driven by COVID-19
Mar 13, 2020
Insights Into the Antiviral Therapeutics Market, 2018-2028 - Featuring 194 Company Profiles and 175 Collaborations